Wealthfront Advisers’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $3.58M | Buy |
9,384
+835
| +10% | +$325K | 0.01% | 505 |
|
|
2026
Q2 | $3.4M | Buy |
8,549
+2,775
| +48% | +$790K | 0.01% | 521 |
|
|
2026
Q1 | $1M | Sell |
5,774
-323
| -5% | -$66.2K | ﹤0.01% | 717 |
|
|
2025
Q4 | $1.56M | Buy |
6,097
+635
| +12% | +$166K | ﹤0.01% | 631 |
|
|
2025
Q3 | $1.42M | Sell |
5,462
-794
| -13% | -$209K | ﹤0.01% | 641 |
|
|
2025
Q2 | $1.53M | Sell |
6,256
-6,640
| -51% | -$1.66M | ﹤0.01% | 610 |
|
|
2025
Q1 | $3.41M | Sell |
12,896
-7,184
| -36% | -$1.94M | 0.01% | 426 |
|
|
2024
Q4 | $5.09M | Buy |
20,080
+6,465
| +47% | +$1.73M | 0.01% | 325 |
|
|
2024
Q3 | $4.31M | Buy |
13,615
+1,581
| +13% | +$563K | 0.01% | 336 |
|
|
2024
Q2 | $4.5M | Sell |
12,034
-1,472
| -11% | -$497K | 0.02% | 299 |
|
|
2024
Q1 | $4.68M | Buy |
13,506
+903
| +7% | +$342K | 0.02% | 283 |
|
|
2023
Q4 | $5.77M | Buy |
12,603
+2,771
| +28% | +$1.37M | 0.02% | 214 |
|
|
2023
Q3 | $4.78M | Buy |
9,832
+490
| +5% | +$230K | 0.02% | 221 |
|
|
2023
Q2 | $4.18M | Sell |
9,342
-658
| -7% | -$331K | 0.02% | 255 |
|
|
2023
Q1 | $4.85M | Sell |
10,000
-4,431
| -31% | -$2.19M | 0.02% | 209 |
|
|
2022
Q4 | $7.39M | Buy |
14,431
+7,078
| +96% | +$3.72M | 0.04% | 148 |
|
|
2022
Q3 | $3.57M | Buy |
7,353
+363
| +5% | +$177K | 0.02% | 241 |
|
|
2022
Q2 | $3.27M | Buy |
6,990
+1,006
| +17% | +$448K | 0.02% | 269 |
|
|
2022
Q1 | $2.6M | Buy |
5,984
+758
| +15% | +$317K | 0.01% | 340 |
|
|
2021
Q4 | $2.42M | Buy |
5,226
+478
| +10% | +$212K | 0.01% | 345 |
|
|
2021
Q3 | $1.85M | Buy |
4,748
+17
| +0.4% | +$7.22K | 0.01% | 365 |
|
|
2021
Q2 | $2.1M | Buy |
4,731
+336
| +8% | +$147K | 0.01% | 293 |
|
|
2021
Q1 | $1.84M | Buy |
4,395
+337
| +8% | +$135K | 0.01% | 291 |
|
|
2020
Q4 | $1.66M | Sell |
4,058
-377
| -9% | -$157K | 0.01% | 266 |
|
|
2020
Q3 | $1.84M | Sell |
4,435
-146
| -3% | -$58.7K | 0.01% | 201 |
|
|
2020
Q2 | $1.78M | Buy |
4,581
+775
| +20% | +$290K | 0.01% | 189 |
|
|
2020
Q1 | $1.2M | Sell |
3,806
-301
| -7% | -$102K | 0.01% | 238 |
|
|
2019
Q4 | $1.5M | Buy |
4,107
+621
| +18% | +$197K | 0.01% | 240 |
|
|
2019
Q3 | $891K | Buy |
3,486
+106
| +3% | +$29.7K | 0.01% | 310 |
|
|
2019
Q2 | $897K | Sell |
3,380
-44
| -1% | -$11.2K | 0.01% | 302 |
|
|
2019
Q1 | $911K | Sell |
3,424
-657
| -16% | -$189K | 0.01% | 275 |
|
|
2018
Q4 | $1.17M | Buy |
+4,081
| New | +$1.29M | 0.01% | 210 |
|
Other funds holding HUM
Wealthfront Advisers's HUM Position: Q3 2026 in Review
Wealthfront Advisers increased its Humana (HUM) stake by 9.8% in Q3 2026, buying an estimated $325K and bringing the position to 9,384 shares worth $3.58M. The position accounts for 0.01% of the portfolio, ranked #505.
Wealthfront Advisers first reported a position in HUM in Q4 2018 and has held it in 32 quarters since. The position peaked at $7.39M in Q4 2022. 746 funds tracked by Wall St. Rank hold HUM as of Q3 2026.
- Wealthfront Advisers held 9,384 shares of Humana worth $3.58M as of Q3 2026.
- Wealthfront Advisers bought 835 Humana shares in Q3 2026, an estimated $325K.
- Humana made up 0.01% of Wealthfront Advisers's portfolio in Q3 2026, its #505 holding.
- Wealthfront Advisers first reported a position in Humana in Q4 2018 and has held it in 32 quarters since.
- Wealthfront Advisers's Humana position peaked at $7.39M in Q4 2022.
- 746 funds tracked by Wall St. Rank held Humana as of Q3 2026.
Based on Wealthfront Advisers's 13F filing for Q3 2026, filed 9 Nov 2026.